| Name | Title | Contact Details |
|---|---|---|
Mary Ladonna |
Director Human Resources | Profile |
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Addiction Prevention is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medco is a leading pharmacy benefit manager (PBM), with the nation's largest mail order pharmacy operations. Medco Pharmacy operates 10 mail-order pharmacies and partners with a nationwide network of approximately 60,000 retail pharmacies. Medco’s automated pharmacies located in Las Vegas, Indianapolis, and Willingboro, NJ, together have the capacity to fill more than 3 million prescriptions per week. Medco Health Solutions, Inc. is an American Pharmacy Benefits Management (PBM) company currently serving the needs of more than 65 million people. Medco provides pharmacy services for private and public employers, health plans, labor unions, government agencies, and individuals served by Medicare Part D Prescription Drug Plans. Medco is a member of the S&P 500 and is ranked number 34 on the 2011 Fortune 500 list, with 2011 revenues of more than $70 billion. It has earned the No. 1 ranking in the Healthcare: Pharmacy and Other Services category on Fortune magazine’s World’s Most Admired Companies list for five consecutive years (2008-2012). Medco was originally founded as National Pharmacies in 1983. In 1984, after an IPO, National Pharmacies became Medco Containment Services, LLC. In 1990, Medco Containment was acquired by Merck & Co., Inc. and became Merck-Medco. In August 2003, Medco Health Solutions, Inc. became an independent company in one of the largest domestic spin-offs at the time. It has recently been acquired by Express Scripts
Los Ninos Services is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
What if one solution could change everything you thought you knew about Diabetes?